Weill Cornell Medicine Works to Address COVID Vaccine Hesitancy, Access
April 16, 2021 With vaccine availability growing in New York City and across the country, attention is increasingly turning to those who are eligible but hesitant about getting the shot
COVID-19, Vaccines and Abnormal Blood Clotting
April 15, 2021 Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting, COVID-19 and vaccines.
Prefrontal Cortex of Brain Provides Feedback to Redirect Attention
April 15, 2021 To enable animals to shift their attention in response to changing circumstances, the prefrontal cortex of the brain helps keep track of which types of stimuli have recently been most relevant, suggests a preclinical study by Weill Cornell Medicine and NewYork-Presbyterian investigators
Dr. Katharine Hsu Named Director of Tri-Institutional M.D.-Ph.D. Program
April 9, 2021 Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
Computer Modeling of SARS-CoV-2 Paves Way for Better COVID-19 Drugs
April 8, 2021 Weill Cornell Medicine scientists have developed a detailed structural model of how the SARS-CoV-2 virus penetrates host cells to establish an infection. 
Center for Virtual Care Expands Training Programs Amid Rising Use of Digital Health
April 7, 2021 Digital health and the tools for patients to virtually reach their healthcare providers have quickly become a mainstay of medical care during the pandemic. Weill Cornell Medicine’s Center for Virtual Care is positioned at the leading edge of this healthcare delivery transformation.
Awards and Honors Across Weill Cornell Medicine - March 31, 2021
March 31, 2021 Awards, honors, prizes and achievements for the month of March.
Researchers Create Rapid Diagnostic Tests and Multi-Omics Analytics Platforms for SARS-CoV-2 Infection
March 30, 2021 Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially-resolved tissue mapping tools were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.
New Technique Provides Detailed Map of Lung Pathology in COVID-19
March 29, 2021 A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
Study in Mice Suggests Radiation Therapy May Be an Important Addition to Personalized Vaccination for Cancer
March 26, 2021 Radiation therapy appears to increase or upregulate the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Calendar of Events